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The clinical phenotype of dementia with Lewy bodies (DLB) is different from Alzheimer’s disease (AD),
suggesting a divergence between these diseases in terms of brain network organization. To fully
understand this, we studied functional networks from resting-state functional magnetic resonance
imaging in cognitively matched DLB and AD patients. The DLB group demonstrated a generalized lower
synchronization compared with the AD and healthy controls, and this was more severe for edges con-
necting distant brain regions. Global network measures were significantly different between DLB and AD.
For instance, AD showed lower small-worldness than healthy controls, while DLB showed higher small-
worldness (AD < controls < DLB), and this was also the case for global efficiency (DLB > controls > AD)
and clustering coefficient (DLB < controls < AD). Differences were also found for nodal measures at brain
regions associated with each disease. Finally, we found significant associations between network per-
formance measures and global cognitive impairment and severity of cognitive fluctuations in DLB. These
results show network divergences between DLB and AD which appear to reflect their neuropathological
differences.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction series of systems or networks such as the default modeDementia with Lewy bodies (DLB) is an increasingly recognized
cause of dementia, accounting for 4%e8% of dementia cases
(McKeith et al., 2007). Diagnostically, it is characterized by 3 core
symptoms: cognitive fluctuations, visual hallucinations, and
parkinsonism (Calderon et al., 2001; Collerton et al., 2003).
Alzheimer’s disease (AD) accounts for 50%e70% of the cases
(McKeith et al., 2007), with memory loss as the main presenting
symptom (Calderon et al., 2001). Although substantial previous
research has achieved a criteria for the clinical differentiation of
DLB to other dementias such as AD (McKeith et al., 1996, 2005), at
early stages the clinical phenotypes of these 2 diseases can overlap
(Tiraboschi et al., 2006; Troster, 2008). This encourages research on
the understanding of the etiological mechanisms of both diseases.
A neuroimaging alternative that can be used to understand DLB
is resting-state functional magnetic resonance imaging (rs-fMRI).
During resting-state intrinsic brain connectivity manifests in aience, Biomedical Research
castle University, Newcastle
c.uk (L.R. Peraza).
Inc. This is an open access articlenetwork (Raichle et al., 2001). These resting-state networks are
considered a functional reflection of structural brain connectivity
(Beckmann et al., 2005), which can be altered by neurodegenerative
diseases as evidenced in previous rs-fMRI studies (Binnewijzend
et al., 2012; Greicius et al., 2004; Seeley et al., 2009).
One approach to studying brain’s functional connectivity is by
building a graph whose topological characteristics reflect neural
communication among brain regions (Eguiluz et al., 2005;
Wang et al., 2010). Such systems can be analyzed using graph
theory, which provides a powerful series of tools that help to
understand and describe the brain’s complexity globally and
regionally (Kaiser, 2011; Rubinov and Sporns, 2010; Sporns et al.,
2004). Brain network analysis has been shown to be a reliable
method across neuroimaging modalities (Buchanan et al., 2014;
Wang et al., 2011), and substantial research has been accom-
plished for the study of AD (He et al., 2009; Stam et al., 2007;
Tijms et al., 2013). However, to date there have been no compara-
ble studies in DLB.
In the present study, we therefore sought to characterize how rs-
fMRI brain networks are altered in DLB using graph theory and to
contrast our findings against a healthy control group, as well as an
AD cohort, to determine DLB-specific network alterations. Our hy-
potheses were that: (1) DLB patients would show altered networkunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Functional network inference and network scores for unweighted, undirected connectivity matrices. (A) A weighted connectivity matrix is inferred from fMRI time series,
then thresholded to a desired edge density or average node degree where the surviving edges become 1 second and the rest 0 seconds. Then, network scores can be applied to the
resultant network. (B) Network measures used to characterize functional brain networks in dementia with Lewy bodies and Alzheimer’s disease patients shown in local and global
versions. All network measures were estimated using the Brain Connectivity Toolbox (Rubinov and Sporns, 2010). Abbreviation: fMRI, functional magnetic resonance imaging.
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with controls, as is commonly reported in the literature for AD; (2)
DLB and AD patients would have different topographic network
alterations given their differing etiological bases, and thus, we
would expect different patterns of expression in local network
measures between the diseases; and (3) cognitive and core symp-
toms in DLB would map onto alterations in network measures.
2. Methods
2.1. Participants and assessment
The study involved 63 participants; 22 diagnosed as DLB, 24 as
AD, and 17 healthy controls. Patients were recruited from the local
population who had been referred to local old age psychiatry and
neurology services. Diagnostic classification of patient groups was
carried out by 2 independent experienced clinicians. Participants
with AD fulfilled the National Institute of Neurological and
Communicative Diseases and Stroke/Alzheimer’s Disease and
Related Disorders Association criteria for probable AD (McKhann
et al., 2011). DLB patients met criteria for probable DLB, including
the presence of 2 of 3 core symptoms; cognitive fluctuations, visual
hallucinations, and parkinsonism (McKeith et al., 2005). Eleven out
of the 22 DLB patients had dopaminergic imaging, and of these all
had reduced bilateral uptake of tracer within their striata. Clinical
assessment included the Mini-Mental State Examination (MMSE),
Cambridge Cognitive Examination (CAMCOG), Unified Parkinson’s
disease rating scale (UPDRS) (Fahn and Elton, 1987). Caregiverswere asked to complete the Clinical Assessment of Fluctuations
(CAF) (Walker et al., 2000), and the Neuropsychiatric Inventory
(NPI) (Cummings et al., 1994), with a particular focus on the
hallucinations subscale (NPIhall) from a visual hallucinations
perspective. Most of the patients were taking acetylcholinesterase
inhibitors (AChEI; 21 DLBs and 24 Alzheimer’s). The control group
had no history of psychiatric or neurological brain disease and a
MMSE score >27. Approval for this study was granted by the
Newcastle Ethics Committee and all participants gave informed
consent.2.2. Imaging preprocessing and time series extraction
For the resting-state, participants laid within the magnetic
resonance imaging scanner with eyes open and a total of
128 functional magnetic resonance imaging (fMRI) volumes were
acquired (repetition time ¼ 3000 ms). fMRI preprocessing
was implemented using the FMRIB’s Software Library (FSL 4.1;
www.fmrib.ox.ac.uk/fsl). It included FMRIB’s Linear Image Regis-
tration Tool for motion correctionwith spatial smoothing full width
at half maximum of 6.0 mm, and high pass filter of 150 seconds.
Structural and functional MRIs were nonlinearly coregistered to
standard space Montreal Neurological Institute using FMRIB’s
nonlinear image registration tool. Motion parameters were
analyzed for movement exclusion criteria (translations >2 mm and
rotations >1) as in Liao et al. (2010), Ni et al. (2012), and com-
parisons between groups for motion/rotationwere evaluated by the
head motion=rotation ¼ ðM  1Þ1
XM
i¼2
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
jxi  xi1j2 þ jyi  yi1j2 þ jzi  zi1j2;
q
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3 motion/rotation parameters and M is the fMRI length.
To further clean the fMRI data sets, Multivariate Exploratory
Linear Optimized Decomposition into Independent Components
was carried out on each of the participant’s fMRIs using standard-
ized cleaning procedures (Kelly et al., 2010). Components resem-
bling artefacts such as movement and cerebrospinal fluid, or whose
power spectra were widespread through all frequencies or above
0.10 Hz were filtered out. Time series extraction was then imple-
mented using 6-mm spheres from 100 cortical and 4-mm spheres
from 12 subcortical regions of interest (ROIs). ROI coordinates were
obtained from the Harvard-Oxford cortical/subcortical atlas in
FMRIB’s Software Library in standard MNI space. Then, the MNI
coordinates were spatially transformed to fMRI participant space
using the coregistration parameters. With the fMRI time series,
Pearson correlation matrices were computed.
Previous investigations in rs-fMRI and Lewy body diseases have
found the presence of functional anticorrelations in DLB
(Galvin et al., 2011) and Parkinson’s disease (PD) (Hacker et al.,
2012). Because of this, and because we were interested in assess-
ing brain connectivity regardless of whether it was positive or
negative in our patient groups (De Vico Fallani et al., 2014), we took
the absolute value of the correlation matrix for further graph
analysis (Li et al., 2013). A schematic diagram showing the network
inference steps is shown in Fig. 1A. ROIs, their coordinates and la-
bels are listed in Supplementary Table 1.
2.3. Graph analysis
Brain networks are represented by graphs where ROIs are
nodes and their interactions are edges or connections. We opted for
the analysis of binary connectivity matrices obtained from the
correlation matrices by thresholding these by edge density
(van Wijk et al., 2010). This avoids obvious differences in the
strength of the connectivity values between patients and controls,
and focuses on the comparison of functional brain networks
(De Vico Fallani et al., 2014).
Different measures have been developed to characterize
network topologies. Networkmeasures used in our study are brieflyTable 1
Demographic, clinical, and cognitive measures
Demographic, clinical, and cognitive measures DLB (n ¼ 18)
Male:female 13:5
Age 77.2  6.18
MMSE 23.6  3.9
UPDRS 17.44  7.8
CAMCOG 76.2  13.5
CAF scale 3.29  4.06e
NPI total 8.71  5.47e
NPI hallucinations 1.65  1.83e
Values expressed as mean  1 standard deviation.
Key: AD, Alzheimer’s disease; CAF, Clinical Assessment of Fluctuating Confusion; CAMCO
controls; MMSE, Mini-Mental State Examination; na, not applicable; NPI, Neuropsychiat
a c2 test, DLB, AD, and HC.
b Analysis of variance DLB, AD, and HC.
c Student t test AD and DLB.
d Student t test HC and AD.
e (n ¼ 17).
f (n ¼ 18).explained in Fig. 1B and further explained in previous published
tutorials (Kaiser, 2011; Newman, 2003; Rubinov and Sporns, 2010;
Stam and Reijneveld, 2007). All network measures in our study
were estimated using the Brain Connectivity Toolbox (Rubinov and
Sporns, 2010) in Matlab (MATLAB 7.14, The MathWorks Inc, Natick,
MA, USA). With this, a battery of 3 analyses was implemented to
study functional networks in our participants as explained in the
following paragraphs:
2.3.1. Edge strength and distance analysis
To compare topological differences between groups, network
edges in all participants were classified as short, middle, and long,
depending on the spatial Euclidean distance between 2 directly
connected nodes. The boundaries for the distance range classifi-
cation were chosen by identifying the longest and shortest
possible distance between 2 nodes and dividing their difference
into 3 equal ranges (short 2.82e56.63 mm, middle
56.63e110.43 mm, and long 110.43e164.23 mm according to the
MNI space). For group comparisons, networks were thresholded at
a range of network densities from 3.6% to 39.3%, in agreement to
previous brain connectivity studies (Bohr et al., 2012; Gießing
et al., 2013; van Wijk et al., 2010). Subsequently, edge strength
and number of edges at each distance range were compared be-
tween groups.
2.3.2. Local network measures
Three nodal network measures were studied: node degree,
nodal clustering coefficient (Watts and Strogatz, 1998), and nodal
betweenness centrality (Freeman, 1978). Node degree provides a
measure of the number of edges connected to each node, where 2
nodes are said to be neighbors when directly connected by an edge,
and nodal betweenness centrality measures the number of shortest
paths that cross a node. A region with high node degree is highly
connected to other regions, whereas a region with high between-
ness centrality would be a region easily reached by distant parts of
the network. Nodal clustering coefficient measures the ratio of a
node’s connected neighbors relative to the maximum number of
connections among them. Brain functional networks often show
high clustering coefficient because neuronal communicationAD (n ¼ 19) HC (n ¼ 17) p-value
16:3 14:3 c2 ¼ 0.93, p ¼ 0.62a
74.7  8.5 76.8  5.7 F2,51 ¼ 0.671, p ¼ 0.516b
22.58  2.9 29.1  0.85 t35 ¼ 0.91, p ¼ 0.36c
1.74  1.8 1.41  1.87 t34 ¼ 0.53, p ¼ 0.59d
72.2  11.5 96.4  3.37 t35 ¼ 0.97, p ¼ 0.33c
0.61  1.54f na t33 ¼ 2.61, p ¼ 0.006c
6.33  7.07f na t33 ¼ 1.10, p ¼ 0.277c
0.0  0.0f na t33 ¼ 3.81, p < 0.001c
G, Cambridge Cognitive Examination; DLB, dementia with Lewy bodies; HC, healthy
ric Inventory; UPDRS, Unified Parkinson’s Disease Rating Scale.
Fig. 2. Connectivity strength analysis between groups. Mean correlation strength for the 3 groups (healthy controls [HC], dementia with Lewy bodies [DLB], and Alzheimer’s disease
[AD]) at 3 edge distance ranges (short, middle, and long) according to their Euclidean distance between nodes. Error bars indicate 1 standard deviation from the mean. As expected,
the control group showed higher mean connectivity strength, while the 2 patient groups showed lower correlation strength. “#” stands for results that were significant after
analysis of variance test (p-value < 0.05) with post-hoc Bonferroni correction (p-value < 0.05/3). “*” stands for significant results at p-value < 0.05, 2-tailed unpaired t test,
uncorrected.
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2009; Newman, 2006b).
2.3.3. Global network measures
Five global network measures were studied: characteristic path
length L (Watts and Strogatz, 1998), clustering coefficient C, global
efficiency E (Latora and Marchiori, 2001), modularity Q (Newman,
2006a, 2006b), and small-worldness s (Humphries and Gurney,
2008). L measures the average shortest path between any 2 nodesFig. 3. Comparisons between groups for global network measures at different edge densities
average across this range of edge densities (shown as box plots at the right of each network
length L, global efficiency E, modularity Q, normalized clustering Cnorm, normalized path leng
showed higher E and lower C compared with healthy controls (HC) and Alzheimer’s diseas
indicate 1 standard deviation from the mean. Triangular and squared markers are indicat
correction) between studied groups at the indicated edge densities. Asterisks (*) show sign
tegrated network measures estimated from each participant.within the network. C is the average of all nodal clustering
coefficients. E is the average inverse of L, and it is indicative of
efficient communication among brain nodes or communities.
Q measures how separated brain communities are among them-
selves; previous research has shown that the functional brain tends
to be modular (Meunier et al., 2010). Small-worldness measures
how well-connected the brain network is both locally and globally
(Power et al., 2010), and it is estimated as the ratio between the
normalized clustering coefficient Cnorm and the normalizedfrom 3.6% to 39.6% (shown as curves) and using integrated network measures, that is,
measure’s curve). Measures assessed were: clustering coefficient C, characteristic path
th Lnorm, and small-worldness s. On average, dementia with Lewy body (DLB) patients
e (AD) patients. Small-worldness is also higher in DLB compared with AD. Error bars
ive of significant differences (analysis of variance [ANOVA] with post-hoc Bonferroni
ificant differences (2-tailed unpaired t tests) between the indicated groups using in-
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dividing C by the clustering coefficient of a random network Crand of
equal node degree distribution leading to C/Crand, and similarly for
Lnorm; L/Lrand (Humphries and Gurney, 2008). To estimate Crand and
Lrand, we used the average indices of 50 random networks preser-
ving the node distribution of the real networks (Sanz-Arigita et al.,
2010). A small-worldness higher than 1 means that the network
showed efficient connectivity (Sporns et al., 2004). Previous
research consistently reports that the brain has a small-world
network architecture (Sporns et al., 2004; Stam and Reijneveld,
2007; van den Heuvel et al., 2008) and that the brain’s small-
worldness is altered in AD, probably due to network disconnec-
tions driven by neural degeneration (Delbeuck et al., 2003). We also
report Cnorm and Lnorm as part of our results.2.4. Statistical analysis
Statistics for demographic and clinical variables were per-
formed using Statistical Package for Social Sciences (version 22).
Head motion and rotation were assessed in Statistical Package for
Social Sciences by 2 Kruskal-Wallis tests. Connectivity values
between groups for short, middle, and long edges were assessed
by 3-level analyses of variance (p-value < 0.05) with post hoc
Bonferroni corrected (p-value < 0.05/3) unpaired t tests in Mat-
lab. Significant differences for global network measures were
assessed using 3-level analysis of variance (p-value < 0.05) with
post hoc Bonferroni corrected unpaired t tests (p-value < 0.05/3,
Matlab) along all network densities. We also estimated integrated
global network measures by averaging their values through all
assessed edge densities (Ginestet et al., 2011), and tested for
statistical differences using 2-tailed unpaired t tests. This inte-
gration solves the multiple comparisons problem caused by
assessing several edge densities (Gießing et al., 2013). Compari-
sons for local network measures were assessed with 2-tailed
unpaired t tests (p-value < 0.05 uncorrected). The number of
times significance was reached per node and edge density was
measured by its nodal consistency Si (Zhao et al., 2012), which
provides an exploratory measure of local network differences
between groups (see Supplementary Material). Finally, integrated
network measures were compared with clinical scores (MMSE,
CAMCOG, CAF, NPIhall, and UPDRS) using Spearman’s rank corre-
lations (Matlab).3. Results
Of the 63 participants, 2 AD patients were excluded from
the study because of coregistration problems. Additionally, 4 DLB
and 3 AD patients were also excluded due to excessive head
motion and/or rotation (>2 mm translation). The motion and/or
rotation parameters of the remaining cohort (18 DLBs, 19 ADs,
and 17 healthy controls) were <2 mm for translation and <1
for rotation. Furthermore, head motion and/or rotationFig. 4. Local network measure comparisons; node degree, clustering coefficient, and
betweenness centrality for comparisons between groups; controls versus Alzheimer’s
disease (AD), Controls versus dementia with Lewy bodies (DLB), and DLB versus AD.
Spheres are proportional to the consistency value S through all edge densities with a
minimum value of S ¼ 1 and maximum of S ¼ 41 if the difference was significant at all
densities from 3.6% to 39.6%. For node names and a list of consistency values, see
Supplementary Tables 1e4. Brains were plotted using BrainNet Viewer (Xia et al.,
2013).
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3.1. Demographic and clinical measures
Statistical comparisons of demographic and clinical variables are
shown in Table 1. The 3 groups were matched for age, with DLB and
AD patients matched for MMSE and CAMCOG scores. Both patient
groups were more cognitively impaired than controls. Cognitive
fluctuation severity and frequency assessed by the CAF were higher
in DLB than AD. For the NPI, both patient groups were matched in
terms of the overall score, but DLB patients had higher subscale
scores (NPIhall) for the frequency and severity of hallucinations.
3.2. Spatial distance and strength of connections
Fig. 2 shows the average correlation for 3 edge distance ranges
(short, middle, and long). Correlation strength was lower in DLB
compared with AD for all 3 ranges (p-value < 0.015). Similarly,
correlation strength in DLB was significantly lower than controls for
middle and long edges (p-value < 0.05); for AD versus controls,
edge strength was not significantly different for any of the 3 ranges.
Additionally, the number of edges was counted at each network
density for each participant. The number of middle and long-range
edges in the 3 groups was not significantly different. However,
when studying the presence of short edges, the number of these
were significantly higher in the DLB group compared with AD
(p-value < 0.05) at network densities 17.1%, 18.9%, and 21.6%
(Supplementary Material).
3.3. Global network measures
Statistical comparisons for the global network measures (inte-
grated and nonintegrated) are shown in Fig. 3. The DLB group
showed higher global efficiency E than the AD and healthy controls.
Significant differences for E were obtained between DLB and AD
patients at densities 16.2%e34.2% and for DLB versus controls at
19.8%e30.6%. AD and controls did not show significant differences
for E. The characteristic path length Lwas significantly lower in DLB
compared with controls and Alzheimer’s at densities 31.5%e39.6%
and 18.9%e39.6%, respectively. Modularity Q did not show signifi-
cant differences, but there was a trend for higher modularity in DLB
and lower modularity in AD compared with controls.
The normalized clustering coefficient Cnorm showed different
results to the non-normalized score: Cnormwas on average higher in
DLB than in controls and Alzheimer’s patients for the entire rangeFig. 5. Spearman’s rank correlations between clinical scores in dementia with Lewy body (D
along all edge densities) in the same group. The MMSE and CAMCOG scores, both measures o
Furthermore, the MMSE showed a negative correlation with the normalized characteristic pa
with DLB, also showed a significant positive correlation with the normalized characteristic p
35), while the rest of the significant correlations are shown as uncorrected (p-value < 0.05). A
Examination; MMSE, Mini-Mental State Examination.edge densities. The normalized characteristic path length Lnormwas
significantly higher in AD than in DLB patients for densities 15.3%e
39.6%. Small-worldness s did not show significant differences, but it
was on average higher in DLB than in controls and AD.
When integrated across the range of edge densities, global
network measures still showed significant differences (box plots in
Fig. 3). The DLB group showed lower C than healthy controls
(p-value ¼ 0.036) and lower Lnorm compared with AD (p-value ¼
0.024). Also, DLB showed higher integrated E (p-value ¼ 0.018) and
s (p-value ¼ 0.038) than AD patients.
3.4. Local network measure comparisons
Each brain plot in Fig. 4 shows network nodes with significantly
different nodal measure values (p-value < 0.05) evaluated through
all edge densities. The size of the spheres is proportional to the
nodal consistency Si (Zhao et al., 2012) for significant differences
across densities, that is, bigger spheres indicate that the region was
significant in terms of nodal consistency Si at several densities with
a maximum value of Si ¼ 41, if the difference was significant at all
densities; 3.6%e39.6% (equivalent to an average node degree from
4 to 44 edges per node; see Supplementary Material).
Regional differences were found by the 3 local network mea-
sures for DLB versus AD. DLB patients showed higher node degree
in temporal lobes compared with AD, including both hippocampi,
while nodes with lower degree were found at posterior areas (pa-
rietal and occipital) in DLB patients. In addition, the right frontal
lobe showed nodes with higher node degree in DLB when
compared with AD. For nodal clustering coefficient, widespread
brain areas covering frontal, parietal and occipital lobes showed
lower scores in DLB. In contrast to DLB, AD patients demonstrated
lower clustering coefficient in temporal cortices and the right oc-
cipital pole. Betweenness centrality showed less regionalized dif-
ferences between the patient groups.
Comparisons for controls versus DLB patients on node degree
revealed lower scores in DLB primarily at parietal and posterior
temporal cortices. Nodal clustering coefficient was lower in DLB
compared with controls in most of the brain cortex, with fewer
differences in occipital lobes. In DLB both thalamic nodes showed
higher node degree, and the left hippocampus showed lower node
degree compared with controls. Betweenness centrality demon-
strated lower scores at temporal and parietal regions in DLBs
compared with controls.
Comparisons between controls and AD patients showed fewer
differences than controls versus DLB. AD patients showed lower
scores for node degree and clustering coefficient primarily at bothLB) and integrated global network measures (the network measure average estimated
f cognitive impairment, showed a positive significant correlation with global efficiency.
th length. The CAF score, which measures the level of cognitive fluctuations in patients
ath length. “#” stands for results that survived Bonferroni correction (p-value < 0.05/
bbreviations: CAF, Clinical Assessment of Fluctuations; CAMCOG, Cambridge Cognitive
L.R. Peraza et al. / Neurobiology of Aging xxx (2015) 1e10 7temporal poles and frontal lobes. Lower betweenness centrality
was found in AD in temporal regions, cingulate gyri, and superior
parietal lobules.
3.5. Correlation with clinical measures
For DLB, significant correlations were found between MMSE,
CAMCOG, and CAF and integrated global efficiency E and normal-
ized path length Lnorm (Fig. 5), although the correlation between
MMSE and E is the only result that survived Bonferroni correction.
MMSE and CAMCOG are positively correlated with E and the MMSE
is negatively correlated with Lnorm in DLB. The CAF score, which
ranges from 0 (no cognitive fluctuations) to 12 (maximum level of
cognitive fluctuations in our group) showed a positive correlation
with Lnorm. We could not find significant correlations between AD
clinical scores and integrated network measures. We did, however,
find a positive correlation trend in the AD group between clustering
coefficient andMMSE-CAMCOG, and between small-worldness and
CAMCOG at low edge densities (Supplementary Material).
4. Discussion
In this study, we found significant differences in the functional
brain network of DLB patients compared with AD and healthy
controls. First, network alterations in DLB were broader than in AD.
Second, both patient groups showed divergent network alterations
manifested in the integrated global measures. For instance, DLB
patients showed higher small-worldness, while AD patients
showed lower small-world index when both groups were
compared against healthy controls. Finally, we found significant
correlations between cognitive and fluctuating attention clinical
scores and global network measures in DLB.
4.1. Network edge differences in DLB, AD, and healthy controls
Previous studies indicate that connectivity strength tends to be
lower in AD (Binnewijzend et al., 2012; Greicius et al., 2004; Liu
et al., 2013); the lack of significant difference in connectivity
strength between Alzheimer’s and healthy controls in the present
study might be attributed to the mild stage of our Alzheimer’s
group with a relatively high MMSE score (mean, 22.58; standard
deviation, 2.9) compared with other studies (Liu et al., 2013; Zhao
et al., 2012). In support of this, Liu et al., 2013 found strength dif-
ferences for long distance connections in a severely impaired AD
group (MMSE mean, 6.2; standard deviation, 4.9) but not in less
impaired participants. It is probable that during the early stages of
neurodegeneration, compensatory responses are activated to
maintain functional integrity (Backman et al., 2000). In DLB, the
significantly lower functional synchronization might be associated
with the presynaptic dysfunction caused by a-synuclein aggregates
which are present in the brain cortex, even at early stages of the
disease (Kramer and Schulz-Schaeffer, 2007; Schulz-Schaeffer,
2010). These presynaptic aggregates have been implicated in the
impairment of neurotransmitter release which would manifest in
lower synchronization of neuronal groups (Pogarell et al., 2006).
4.2. Altered small-world topology in AD and DLB
One important finding in this study, and contrary to our a priori
hypothesis, was the observation of higher small-worldness in DLB
compared with healthy controls. The AD cohort showed lower
small-worldness than healthy controls, and this finding is in
agreement with most of the previously published research (Sanz-
Arigita et al., 2010; Stam et al., 2007; Supekar et al., 2008). A
decrease of small-worldness has been suggested to arise as a resultof a brain network randomization (Stam et al., 2009) consequent to
the Alzheimer-related pathology.
The higher small-worldness we observed in DLB is driven by a
higher normalized clustering coefficient which is indicative of
higher local connectivity. Certainly, our results on edge distance
comparisons suggest a relative increase of short edges in DLB
compared with controls, which explains the higher clustering co-
efficient and the higher modularity Q shown in our results. The
trend of higher Q in DLB indicates a dissociation of functional brain
modules, suggesting that these are less connected. In contrast,
lower Q in AD has previously been reported (Chen et al., 2013; Sun
et al., 2014), and our results concur with this.
Increases in the number of short range edges in DLB are an effect
of the threshold of the connectivity matrices by edge density (see
Section 2). We observed higher desynchronization of distant brain
regions in DLB as evidenced by significant low correlation strengths
in middle and long distance connections (see Fig. 2). This results in
networks with a more regular topology in DLB, with more con-
nections to the nearest neighbors and more dissociated functional
modules, which additionally leads to the effect of a higher
normalized clustering coefficient and higher small-worldness. This
phenomenon is explained in Telesford et al. (2011), where it is
shown to be dependent on the edge rewiring of the real networks to
estimate Crand and Lrand (Telesford et al., 2011). We present detailed
analyses on this in Supplementary Material.
Higher desynchronization of long distance connections have
been reported using other neuroimaging modalities in Lewy body
dementias (Bosboom et al., 2009; Kai et al., 2005), and this maps
onto the known structural abnormalities in white matter in DLB
(Kiuchi et al., 2011; Watson et al., 2012).
Neurobiological explanations for the network regularization in
DLB remain speculative at this point but could include the signifi-
cant known deficit in cholinergic function which occurs in DLB
(Aarsland et al., 2004; Tiraboschi et al., 2000). Certainly, loss of
cholinergic function may have a deleterious effect on long-range
synchronicity (Bosboom et al., 2009; Kai et al., 2005); and sec-
ondly, deficits of this neurotransmitter might impair the ability of
the cholinergic system to inhibit intracortical communication of
close range neuronal groups, which is the mechanism by which the
brain can enhance thalamocortical communication in the presence
of external stimuli (Kimura et al., 1999; Lucas-Meunier et al., 2003;
Picciotto et al., 2012; Proulx et al., 2014). From a network
perspective, the impact of these changes could be themanifestation
of a relative increase of cortical short distance connections in the
functional network, producing a more regular network topology
with higher small-worldness. Supporting evidence for this comes
from a recent investigation from Baggio et al. (2014) in PD patients
with mild cognitive impairment, whose functional brain network
also presented higher small-worldness compared with healthy
controls.
These ideas also resonate with our previous report in which we
found functional disconnections between the frontoparietal atten-
tion system and basal brain regions associated with cognitive
fluctuations in DLB (Peraza et al., 2014), a symptomwhich has been
speculated to be dependent on cholinergic deficits (Ballard et al.,
2001). However, we are cautious in over-interpreting our find-
ings, as clearly a confounding element was the concurrent use at
the time of scanning of AChEI in our patient groups; previous
research has demonstrated functional connectivity can be restored
in mild AD (Li et al., 2012) and PD patients (Possin et al., 2013).
However, although to date there is no research work assessing in-
fluences in rs-fMRI by this medication in DLB, it is known that DLB
patients have a much more severe deficit in cholinergic function
compared with AD patients (Ballard et al., 2001; Lam et al., 2009).
Thus, we would argue that it is likely that functional alterations
L.R. Peraza et al. / Neurobiology of Aging xxx (2015) 1e108arising as a result of cholinergic dysfunction are still likely to be
evident in DLB despite AChEI treatment.
4.3. Regional network differences in DLB and AD
The lower node degree and nodal clustering in temporal cortices
including both hippocampi in AD and parietal, occipital and frontal
cortices in DLB as shown in Fig. 4, are consistent with the disease-
specific regional predilections in pathology that have been
demonstrated in previous neuroimaging and postmortem studies
(Burton et al., 2004; Watson et al., 2012; Zhou et al., 2008). The
higher node degree in both thalamic nodes in DLB compared with
controls may reflect compensatory responses (Galvin et al., 2011;
Kenny et al., 2012), and it is notable that thalamic alterations
appear apposite to the significant attention deficits and cognitive
fluctuations which occur in DLB (Delli Pizzi et al., 2014).
When comparing AD and control participants, regional differ-
ences are not as obvious as in DLB versus AD and DLB versus con-
trols. Nevertheless, lower node degree, clustering coefficient, and
betweenness centrality were evidenced, particularly in temporal
cortices in AD, thus aligning with the tendency of the Alzheimer-
related pathology to affect these structures early in the disease
course (Firbank et al., 2010; Zhao et al., 2012).
4.4. Correlation with clinical scores in DLB
In the DLB group, the MMSE and CAMCOG scores, measures of
global cognitive function, were correlated with the integrated
global efficiency. In addition, the normalized path length and CAF
score in DLB demonstrated a significant positive correlation, sug-
gesting that inefficient connectivity may contribute to the mani-
festation of cognitive fluctuations in DLB. In contrast, we did not see
any association between global measures and the other DLB core
symptoms of parkinsonism or visual hallucinations. However,
previous investigations suggest that complex visual hallucinations
in DLB are triggered by attention and cognitive deficits (Collerton
et al., 2005; Shine et al., 2011; Uchiyama et al., 2012), symptom
domains whose clinical scores were correlated with global network
metrics in the current investigation. A possible explanation might
be that the symptoms of impaired cognition and attention are so
inter-related with alterations in the functional brain network that
these conceal significant relations with the symptoms of complex
visual hallucinations and parkinsonism, and these are more
regionally specific, for example, visual areas (Heitz et al., 2015;
Taylor et al., 2012) and motor system (Huang et al., 2007). We
conducted exploratory analyses which provided some tentative
support for this conclusion (Supplementary Material).
We did not see any correlations with the clinical scores in the AD
group. One explanation may be that our AD group was less cogni-
tively impaired compared with previous reports, and because of
this, we were only able to find correlation trends of MMSE and
CAMCOG with network measures in AD. In DLB, cognitive impair-
ment and fluctuations appear to depend on the degree of cholin-
ergic dysfunction, and thus these findings provide further support
for the inference that functional network alterations in DLB may
depend on this neurotransmission system, although this must be
taken with the caveat that, we had no direct measure of the degree
of cholinergic dysfunction in our patients as well as the confound
that most of our patients were taking AChEI.
5. Conclusions
Our results of decreased small-worldness and lower nodal
network measures in temporal cortices in AD agree with the cur-
rent consensus in the literature. In DLB, small-worldness wasincreased, which is in contrast to AD results andmay be consequent
to network regularization arising as a result of a relative loss of
long-range connections. We further demonstrated that network
alterations are associated with the degree of cognitive impairment
and cognitive fluctuations in DLB, highlighting the potential of
these metrics as disease biomarkers, as well as providing further
insights into the pathoetiologic mechanisms in this condition.
Future investigations in DLB and across the Lewy body disease
spectrum should consider novel multimodality approaches; see for
instance Whitwell et al. (2012) and Nombela et al. (2014), to better
understand and characterize this dementia and its triggering
mechanisms for an earlier and more accurate clinical diagnosis.
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